Ticker Details
Bio-Techne Corp Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products.
IPO Date:	March 1, 1989
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$11.27B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.48 | 1.20%
Avg Daily Range (30 D):	$0.20 | 0.28%
Avg Daily Range (90 D):	$1.00 | 1.81%

Institutional Daily Volume
Avg Daily Volume:	.37M
Avg Daily Volume (30 D):	2.79M
Avg Daily Volume (90 D):	3.64M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	103
Avg Trade Size (Sh.) (90 D):	99

Institutional Trades
Total Institutional Trades:	9,447
Avg Institutional Trade:	$4.98M
Avg Institutional Trade (30 D):	$8.55M
Avg Institutional Trade (90 D):	$5.83M
Avg Institutional Trade Volume:	.25M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$9.59M
Avg Closing Trade (30 D):	$26.35M
Avg Closing Trade (90 D):	$27.58M
Avg Closing Volume:	401.45K

News

Jul 6, 2026 @ 5:59 PM Halper Sadeh LLC is Investigating Whether ACA, TEC... Source: Halper Sadeh Llc

Jun 25, 2026 @ 9:23 PM Stock Market Today, June 25: Bio-Techne Surges Aft... Source: Josh Kohn-Lindquist

May 6, 2026 @ 5:35 PM S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16%... Source: Piero Cingari

Mar 20, 2026 @ 11:00 AM ELISpot & FluoroSpot Assay Market Report 2026-2031... Source: Researchandmarkets.Com

Feb 4, 2026 @ 11:30 AM Bio-Techne Declares Dividend Source: Prnewswire

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$.71	$.33	$.24
Diluted EPS	$.69	$.32	$.24
Revenue	$1.21B	$311.42M	$295.88M
Gross Profit	$786.49M	$208.29M	$191.28M
Net Income / Loss	$109.56M	$51.05M	$38.01M
Operating Income / Loss	$153.75M	$75.5M	$54.46M
Cost of Revenue	$424.32M	$103.13M	$104.6M
Net Cash Flow	$57.77M	$38.13M	$27.5M
PE Ratio

Splits
Nov 30, 2022	4:1
Nov 10, 2022	4:1
Dec 04, 2000	2:1